{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:03:08Z","timestamp":1788825788055,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,24]]},"DOI":"10.7759\/cureus.84760","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:30:36Z","timestamp":1748133036000},"source":"Crossref","is-referenced-by-count":3,"title":["Systemic Lupus Erythematosus and Psoriasis Overlap: A Case Series"],"prefix":"10.7759","author":[{"given":"Mohannad","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasameen","family":"Abdulhameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103648","article-title":"Immunopathogenesis of systemic lupus erythematosus: an update","volume":"23","author":"Arnaud L","year":"2024","unstructured":"Arnaud L, Chasset F, Martin T. Immunopathogenesis of systemic lupus erythematosus: an update. Autoimmun Rev. 2024, 23:103648. 10.1016\/j.autrev.2024.103648","journal-title":"Autoimmun Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel CH","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024, 331:1480-91. 10.1001\/jama.2024.2315","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.06.004","article-title":"Overlap connective tissue disease syndromes","volume":"12","author":"Iaccarino L","year":"2013","unstructured":"Iaccarino L, Gatto M, Bettio S, et al.. Overlap connective tissue disease syndromes. Autoimmun Rev. 2013, 12:363-73. 10.1016\/j.autrev.2012.06.004","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.22641","article-title":"Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data","volume":"56","author":"Chakravarty EF","year":"2007","unstructured":"Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007, 56:2092-4. 10.1002\/art.22641","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian J","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023, 82:351-6. 10.1136\/ard-2022-223035","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi R","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013, 133:377-85. 10.1038\/jid.2012.339","journal-title":"J Invest Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2340\/00015555195115","article-title":"The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders","volume":"76","author":"Zalla MJ","year":"1996","unstructured":"Zalla MJ, Muller SA. The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders. Acta Derm Venereol. 1996, 76:1-15. 10.2340\/00015555195115","journal-title":"Acta Derm Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15761\/ROM.1000105","article-title":"Association of psoriasis and psoriatic arthritis with systemic lupus erythematosus","volume":"1","author":"Bonilla E","year":"2016","unstructured":"Bonilla E, Shadakshari A, Perl A. Association of psoriasis and psoriatic arthritis with systemic lupus erythematosus. Rheumatol Orthop Med. 2016, 1:1-3. 10.15761\/ROM.1000105","journal-title":"Rheumatol Orthop Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.05.074","article-title":"Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment","volume":"83","author":"Sachdeva M","year":"2020","unstructured":"Sachdeva M, Mufti A, Maliyar K, Lytvyn Y, Yeung J. Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment. J Am Acad Dermatol. 2020, 83:579-86. 10.1016\/j.jaad.2020.05.074","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac129","article-title":"Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review","volume":"61","author":"Vincken NL","year":"2022","unstructured":"Vincken NL, Balak DM, Knulst AC, Welsing PM, van Laar JM. Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review. Rheumatology (Oxford). 2022, 61:4232-44. 10.1093\/rheumatology\/keac129","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12018","article-title":"Photosensitivity in cutaneous lupus erythematosus","volume":"29","author":"Kim A","year":"2013","unstructured":"Kim A, Chong BF. Photosensitivity in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed. 2013, 29:4-11. 10.1111\/phpp.12018","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1874312901206010315","article-title":"Anti-tumor necrosis factor-\u03b1 induced systemic lupus erythematosus","volume":"6","author":"Almoallim H","year":"2012","unstructured":"Almoallim H, Al-Ghamdi Y, Almaghrabi H, Alyasi O. Anti-tumor necrosis factor-\u03b1 induced systemic lupus erythematosus. Open Rheumatol J. 2012, 6:315-19. 10.2174\/1874312901206010315","journal-title":"Open Rheumatol J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8668-1","article-title":"Psoriasis: from pathogenesis to targeted therapies","volume":"54","author":"Conrad C","year":"2018","unstructured":"Conrad C, Gilliet M. Psoriasis: from pathogenesis to targeted therapies. Clin Rev Allergy Immunol. 2018, 54:102-13. 10.1007\/s12016-018-8668-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2018.77665","article-title":"The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor \u03b1 in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis","volume":"35","author":"Pirowska M","year":"2018","unstructured":"Pirowska M, Obtu\u0142owicz A, Lipko-Godlewska S, Go\u017adzialska A, Podolec K, Wojas-Pelc A. The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor \u03b1 in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis. Postepy Dermatol Alergol. 2018, 35:360-6. 10.5114\/ada.2018.77665","journal-title":"Postepy Dermatol Alergol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong CK","year":"2008","unstructured":"Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol. 2008, 127:385-93. 10.1016\/j.clim.2008.01.019","journal-title":"Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2018.0169","article-title":"Changes of serum IL-6, IL-17, and complements in systemic lupus erythematosus patients","volume":"39","author":"Tang Y","year":"2019","unstructured":"Tang Y, Tao H, Gong Y, Chen F, Li C, Yang X. Changes of serum IL-6, IL-17, and complements in systemic lupus erythematosus patients. J Interferon Cytokine Res. 2019, 39:410-15. 10.1089\/jir.2018.0169","journal-title":"J Interferon Cytokine Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914413","article-title":"Cytokines in systemic lupus erythematosus\u2014focus on TNF-\u03b1 and IL-17","volume":"24","author":"Richter P","year":"2023","unstructured":"Richter P, Macovei LA, Mihai IR, Cardoneanu A, Burlui MA, Rezus E. Cytokines in systemic lupus erythematosus\u2014focus on TNF-\u03b1 and IL-17. Int J Mol Sci. 2023, 24:14413. 10.3390\/ijms241914413","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06554.x","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"5","author":"Kuhn A","year":"2007","unstructured":"Kuhn A, Sticherling M, Bonsmann G. Clinical manifestations of cutaneous lupus erythematosus. J Dtsch Dermatol Ges. 2007, 5:1124-37. 10.1111\/j.1610-0387.2007.06554.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(83)70069-1","article-title":"Serologic studies in patients with lupus erythematosus and psoriasis","volume":"8","author":"Kulick KB","year":"1983","unstructured":"Kulick KB, Mogavero H Jr, Provost TT, Reichlin M. Serologic studies in patients with lupus erythematosus and psoriasis. J Am Acad Dermatol. 1983, 8:631-4. 10.1016\/s0190-9622(83)70069-1","journal-title":"J Am Acad Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.893827","article-title":"The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets","volume":"10","author":"Shao WH","year":"2014","unstructured":"Shao WH, Cohen PL. The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets. Expert Rev Clin Immunol. 2014, 10:573-82. 10.1586\/1744666X.2014.893827","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/360190-systemic-lupus-erythematosus-and-psoriasis-overlap-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:30:37Z","timestamp":1748133037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/360190-systemic-lupus-erythematosus-and-psoriasis-overlap-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84760","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,24]]}}}